Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetWages, Salaries and Other
Ratios

Ptc Therapeutics (PTCT) Leases (2019 - 2025)

Ptc Therapeutics has reported Leases over the past 7 years, most recently at $80.1 million for Q4 2025.

  • Quarterly results put Leases at $80.1 million for Q4 2025, up 41.22% from a year ago — trailing twelve months through Dec 2025 was $80.1 million (up 41.22% YoY), and the annual figure for FY2025 was $80.1 million, up 41.22%.
  • Leases for Q4 2025 was $80.1 million at Ptc Therapeutics, down from $80.7 million in the prior quarter.
  • Over the last five years, Leases for PTCT hit a ceiling of $141.6 million in Q2 2022 and a floor of $56.2 million in Q2 2025.
  • Median Leases over the past 5 years was $80.7 million (2021), compared with a mean of $83.3 million.
  • Biggest five-year swings in Leases: skyrocketed 173.77% in 2021 and later tumbled 40.91% in 2024.
  • Ptc Therapeutics' Leases stood at $77.4 million in 2021, then surged by 32.3% to $102.4 million in 2022, then decreased by 10.28% to $91.9 million in 2023, then plummeted by 38.32% to $56.7 million in 2024, then skyrocketed by 41.22% to $80.1 million in 2025.
  • The last three reported values for Leases were $80.1 million (Q4 2025), $80.7 million (Q3 2025), and $56.2 million (Q2 2025) per Business Quant data.